Zofenopril: Difference between revisions
No edit summary |
No edit summary |
||
Line 27: | Line 27: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Zofenopril''' (also known as Zofenoprilum [Latin]) is an [[ACE inhibitor|angiotensin converting enzyme (ACE) inhibitor]] with cardioprotective properties indicated for the treatment of hypertension.<ref>{{cite journal |author=Ambrosioni E |title=Defining the role of zofenopril in the management of hypertension and ischemic heart disorders |journal=Am J Cardiovasc Drugs |volume=7 |issue=1 |pages=17–24 |year=2007 |pmid=17355163 |doi= 10.2165/00129784-200707010-00002|url=}}</ref> | '''Zofenopril''' (also known as Zofenoprilum [Latin]) is an [[ACE inhibitor|angiotensin converting enzyme (ACE) inhibitor]] with cardioprotective properties indicated for the treatment of hypertension.<ref>{{cite journal |author=Ambrosioni E |title=Defining the role of zofenopril in the management of hypertension and ischemic heart disorders |journal=Am J Cardiovasc Drugs |volume=7 |issue=1 |pages=17–24 |year=2007 |pmid=17355163 |doi= 10.2165/00129784-200707010-00002|url=}}</ref> | ||
Line 40: | Line 42: | ||
[[Category:ACE inhibitors]] | [[Category:ACE inhibitors]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]][[Category: | |||
Latest revision as of 21:01, 23 July 2014
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H23NO4S2 |
Molar mass | 429.552 g/mol |
WikiDoc Resources for Zofenopril |
Articles |
---|
Most recent articles on Zofenopril |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Zofenopril at Clinical Trials.gov Clinical Trials on Zofenopril at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Zofenopril
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Zofenopril Discussion groups on Zofenopril Patient Handouts on Zofenopril Directions to Hospitals Treating Zofenopril Risk calculators and risk factors for Zofenopril
|
Healthcare Provider Resources |
Causes & Risk Factors for Zofenopril |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Zofenopril (also known as Zofenoprilum [Latin]) is an angiotensin converting enzyme (ACE) inhibitor with cardioprotective properties indicated for the treatment of hypertension.[1]
In small studies, zofenopril appeared significantly more effective than the older antihypertensives atenolol and enalapril, and was associated with less adverse effects.[2][3]
References
- ↑ Ambrosioni E (2007). "Defining the role of zofenopril in the management of hypertension and ischemic heart disorders". Am J Cardiovasc Drugs. 7 (1): 17–24. doi:10.2165/00129784-200707010-00002. PMID 17355163.
- ↑ Nilsson P (October 2007). "Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension". Blood Press Suppl. 2: 25–30. PMID 18046976.
- ↑ Mallion JM (October 2007). "An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension". Blood Press Suppl. 2: 13–8. PMID 18046974.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- ACE inhibitors
- Cardiovascular Drugs
- Drug